Seeing Medicines
LeRoux is a seasoned biotech executive with recent experience in regenerative medicine and developing stem cell-based treatments for macular degeneration at Ocata Therapeutics (acquired by Astellas Pharma in 2016).
LeRoux has prior experience in big pharma (Eli Lilly, Wyeth, Cephalon) and startup biotech (Aton Pharma, Antares, and Akili Interactive).
This person is not in any teams
This person is not in any offices
Seeing Medicines
Seeing Medicines is a biotech company focused on regenerative ocular treatments. The company's goal is to develop regenerative medicine treatments to restore and maintain vision in people with macular degenerative diseases such as Age-related Macular Degeneration (AMD), Best Disease, and Stargardt Disease.Seeing Medicines was founded in 2020and is based in Arden, NC.